论文信息 - Does anti-VEGF bevacizumab improve survival in experimental sepsis? - 字舞流文

Does anti-VEGF bevacizumab improve survival in experimental sepsis?

E. Brakenhielm | F. Tamion | E. Besnier | V. Richard

[1] C. O. Kim,et al. Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis , 2013, Critical Care.

[2] D. Ganea,et al. Cecal ligation puncture procedure. , 2011, Journal of visualized experiments : JoVE.

[3] D. Angus,et al. A PROSPECTIVE, OBSERVATIONAL STUDY OF SOLUBLE FLT-1 AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN SEPSIS , 2008, Shock.

[4] F. Hsieh,et al. Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis , 2007, Critical care medicine.